"BEST PRICE" DISCOUNTS TO HMOs AND GPOs CONTINUE TO DECREASE
"BEST PRICE" DISCOUNTS TO HMOs AND GPOs CONTINUE TO DECREASE, a General Accounting Office report released Aug. 5 finds. GAO calculated that 21% of HMO best prices on pharmaceuticals increased more than 30% between the first quarter of 1992 and the first quarter of 1993, compared with 18.5% over the previous 12 months. Among group purchasing organizations, 17.7% of best prices increased more than 30% from 1992 to 1993, versus 20.8% for the prior year.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth